Deciphering two decades of cellular reprogramming in cancer: A bibliometric analysis of evolving trends and research frontiers
Recent research has reevaluated the traditional view of cancer's linear progression and recurrence by introducing cellular reprogramming a process in which cancer cells can their state under certain conditions. This change is driven by a combination of genetic and epigenetic factors, with pivot...
Saved in:
| Published in: | Heliyon Vol. 10; no. 11; p. e31400 |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
England
Elsevier Ltd
15.06.2024
Elsevier |
| Subjects: | |
| ISSN: | 2405-8440, 2405-8440 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Recent research has reevaluated the traditional view of cancer's linear progression and recurrence by introducing cellular reprogramming a process in which cancer cells can their state under certain conditions. This change is driven by a combination of genetic and epigenetic factors, with pivotal roles played by key genes, and pathways, notably Wnt and Notch. The complexity of cancer's behavior is further influenced by factors such as the epithelial-mesenchymal transition (EMT) and therapy-induced stress, both of which are significant contributors to cancer recurrence. In this context bibliometric analysis emerges as a crucial tool for evaluating the impacts and trends within scientific literature. Our study utilized bibliometrics to analysis the role of cellular reprogramming oncology over the past two decades, highlighting its potential to improve cancer treatment outcomes. In conducting this analysis, we searched for literature search on cellular reprogramming (CR) in the Web of Science database, covering the years 2002–2022. We employed visualization tools like Citespace, VOSviewer, and Bibliometrix to analyze the collected data resulting in a dataset of 3102 articles. The United States and China emerged as leading contributors to this field, with the University of Texas MD Anderson Cancer Center being the most prolific institution. Menendez was the most influential scholar in this research domain. Cancers was the journal with the most publications on this subject. The most local-cited document was the article titled “Hallmarks of Cancer: The Next Generation”. A comprehensive analysis has been conducted based on keywords and cited references. In recent years, the research emphasis has shifted to “extracellular vesicles,” “cancer therapy,” and “cellular plasticity”. Therefore, this analysis uses bibliometrics to chart cutting-edge progress in cancer's cellular reprogramming, aiding experts to quickly understand and innovate in this crucial area. |
|---|---|
| AbstractList | Recent research has reevaluated the traditional view of cancer's linear progression and recurrence by introducing cellular reprogramming a process in which cancer cells can their state under certain conditions. This change is driven by a combination of genetic and epigenetic factors, with pivotal roles played by key genes, and pathways, notably Wnt and Notch. The complexity of cancer's behavior is further influenced by factors such as the epithelial-mesenchymal transition (EMT) and therapy-induced stress, both of which are significant contributors to cancer recurrence. In this context bibliometric analysis emerges as a crucial tool for evaluating the impacts and trends within scientific literature. Our study utilized bibliometrics to analysis the role of cellular reprogramming oncology over the past two decades, highlighting its potential to improve cancer treatment outcomes. In conducting this analysis, we searched for literature search on cellular reprogramming (CR) in the Web of Science database, covering the years 2002–2022. We employed visualization tools like Citespace, VOSviewer, and Bibliometrix to analyze the collected data resulting in a dataset of 3102 articles. The United States and China emerged as leading contributors to this field, with the University of Texas MD Anderson Cancer Center being the most prolific institution. Menendez was the most influential scholar in this research domain. Cancers was the journal with the most publications on this subject. The most local-cited document was the article titled “Hallmarks of Cancer: The Next Generation”. A comprehensive analysis has been conducted based on keywords and cited references. In recent years, the research emphasis has shifted to “extracellular vesicles,” “cancer therapy,” and “cellular plasticity”. Therefore, this analysis uses bibliometrics to chart cutting-edge progress in cancer's cellular reprogramming, aiding experts to quickly understand and innovate in this crucial area. Recent research has reevaluated the traditional view of cancer's linear progression and recurrence by introducing cellular reprogramming a process in which cancer cells can their state under certain conditions. This change is driven by a combination of genetic and epigenetic factors, with pivotal roles played by key genes, and pathways, notably Wnt and Notch. The complexity of cancer's behavior is further influenced by factors such as the epithelial-mesenchymal transition (EMT) and therapy-induced stress, both of which are significant contributors to cancer recurrence. In this context bibliometric analysis emerges as a crucial tool for evaluating the impacts and trends within scientific literature. Our study utilized bibliometrics to analysis the role of cellular reprogramming oncology over the past two decades, highlighting its potential to improve cancer treatment outcomes. In conducting this analysis, we searched for literature search on cellular reprogramming (CR) in the Web of Science database, covering the years 2002-2022. We employed visualization tools like Citespace, VOSviewer, and Bibliometrix to analyze the collected data resulting in a dataset of 3102 articles. The United States and China emerged as leading contributors to this field, with the University of Texas MD Anderson Cancer Center being the most prolific institution. Menendez was the most influential scholar in this research domain. Cancers was the journal with the most publications on this subject. The most local-cited document was the article titled "Hallmarks of Cancer: The Next Generation". A comprehensive analysis has been conducted based on keywords and cited references. In recent years, the research emphasis has shifted to "extracellular vesicles," "cancer therapy," and "cellular plasticity". Therefore, this analysis uses bibliometrics to chart cutting-edge progress in cancer's cellular reprogramming, aiding experts to quickly understand and innovate in this crucial area.Recent research has reevaluated the traditional view of cancer's linear progression and recurrence by introducing cellular reprogramming a process in which cancer cells can their state under certain conditions. This change is driven by a combination of genetic and epigenetic factors, with pivotal roles played by key genes, and pathways, notably Wnt and Notch. The complexity of cancer's behavior is further influenced by factors such as the epithelial-mesenchymal transition (EMT) and therapy-induced stress, both of which are significant contributors to cancer recurrence. In this context bibliometric analysis emerges as a crucial tool for evaluating the impacts and trends within scientific literature. Our study utilized bibliometrics to analysis the role of cellular reprogramming oncology over the past two decades, highlighting its potential to improve cancer treatment outcomes. In conducting this analysis, we searched for literature search on cellular reprogramming (CR) in the Web of Science database, covering the years 2002-2022. We employed visualization tools like Citespace, VOSviewer, and Bibliometrix to analyze the collected data resulting in a dataset of 3102 articles. The United States and China emerged as leading contributors to this field, with the University of Texas MD Anderson Cancer Center being the most prolific institution. Menendez was the most influential scholar in this research domain. Cancers was the journal with the most publications on this subject. The most local-cited document was the article titled "Hallmarks of Cancer: The Next Generation". A comprehensive analysis has been conducted based on keywords and cited references. In recent years, the research emphasis has shifted to "extracellular vesicles," "cancer therapy," and "cellular plasticity". Therefore, this analysis uses bibliometrics to chart cutting-edge progress in cancer's cellular reprogramming, aiding experts to quickly understand and innovate in this crucial area. |
| ArticleNumber | e31400 |
| Author | Lin, Yijian Zhang, Xinrong Wu, Tongtong Liu, Yuanqing Yin, Weiqiang Liang, Jinghao Tan, Zhaofeng Guo, Zhihua Zhou, Xinyi Xie, Zixian Lin, Hongmiao |
| Author_xml | – sequence: 1 givenname: Jinghao surname: Liang fullname: Liang, Jinghao organization: Department of Thoracic Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China – sequence: 2 givenname: Yijian surname: Lin fullname: Lin, Yijian organization: Second Clinical Medical College, Guangdong Medical University, Dongguan, 523000, China – sequence: 3 givenname: Yuanqing surname: Liu fullname: Liu, Yuanqing organization: Second Clinical Medical College, Guangdong Medical University, Dongguan, 523000, China – sequence: 4 givenname: Hongmiao surname: Lin fullname: Lin, Hongmiao organization: Graduate School, The Sixth Affiliated to Guangzhou Medical University The Sixth People's Hospital, Guangzhou, 510120, China – sequence: 5 givenname: Zixian surname: Xie fullname: Xie, Zixian organization: Department of Thoracic Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China – sequence: 6 givenname: Tongtong surname: Wu fullname: Wu, Tongtong organization: Second Clinical Medical College, Guangdong Medical University, Dongguan, 523000, China – sequence: 7 givenname: Xinrong surname: Zhang fullname: Zhang, Xinrong organization: Second Clinical Medical College, Guangdong Medical University, Dongguan, 523000, China – sequence: 8 givenname: Xinyi surname: Zhou fullname: Zhou, Xinyi organization: Second Clinical Medical College, Guangdong Medical University, Dongguan, 523000, China – sequence: 9 givenname: Zhaofeng surname: Tan fullname: Tan, Zhaofeng organization: Graduate School, The Sixth Affiliated to Guangzhou Medical University The Sixth People's Hospital, Guangzhou, 510120, China – sequence: 10 givenname: Weiqiang orcidid: 0000-0003-1928-0922 surname: Yin fullname: Yin, Weiqiang email: yinweiqiang88@163.com organization: Department of Thoracic Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China – sequence: 11 givenname: Zhihua surname: Guo fullname: Guo, Zhihua organization: Department of Thoracic Surgery, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510120, China |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38832277$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkk1vEzEQhleoiJbSnwDaI5cEf-564YCq8lWpEhc4W7P2bOLIawd7E5QLvx3no6jl0pMtzzvPzHjel9VZiAGr6jUlc0po8241X6J3uxjmjDAxR04FIc-qCyaInCkhyNmD-3l1lfOKEEKlarqWv6jOuVKcsba9qP58QuPWS0wuLOrpd6wtGrCY6zjUBr3feEh1wnWKiwTjuFe5UBsIBtP7-rruXe9dHHFKztQQwO-yOyTjNvrtAZow2FxitnAyQjLLekgxTA5TflU9H8BnvDqdl9XPL59_3Hyb3X3_entzfTczsmmnmeGsH6jsOtYbBS3YgdKhI4xLioAwlGGws9QIbjkTfDCtaaGXvWpMmUchv6xuj1wbYaXXyY2QdjqC04eHmBYa0uSMR60KxCouwTaNgK6B1vKGDsoCiFKCFdbHI2u96Ue0BsOUwD-CPo4Et9SLuNWUUiEZ54Xw9kRI8dcG86RHl_e_DQHjJmtOJVdSCK6elpJGSMU60RTpm4d9_WvoftlF8OEoMCnmnHDQxk0wubhv03lNid67S6_0yV167y59dFfJlv9l3xd4Ku_0XVj2uy1L19k4LP6xLqGZygLcE4S_VUvwWw |
| CitedBy_id | crossref_primary_10_1016_j_nlp_2024_100123 crossref_primary_10_3389_fmed_2024_1451990 crossref_primary_10_1080_21645515_2025_2472493 |
| Cites_doi | 10.1016/j.apsb.2021.10.015 10.1038/s41467-020-14682-6 10.1007/s11684-020-0793-6 10.1038/s41388-018-0480-0 10.1007/s11192-009-0146-3 10.1016/j.canlet.2023.216425 10.1016/j.cmet.2015.12.006 10.1186/s40824-023-00369-8 10.1016/j.cell.2014.01.005 10.1016/j.cmet.2007.10.002 10.1158/2159-8290.CD-21-0502 10.1371/journal.pone.0087893 10.1126/science.1160809 10.1038/msb.2011.56 10.1016/j.cell.2011.02.013 10.3389/fimmu.2021.714822 10.1016/j.cell.2016.08.055 10.1038/s41419-021-03641-8 10.1038/s41568-021-00378-6 10.1038/ng.127 10.1016/j.phrs.2018.03.015 10.1016/j.cmet.2015.08.007 10.1016/j.joi.2017.08.007 10.1038/nbt.2530 10.1016/j.ccell.2022.12.008 10.3390/cancers15194803 10.1016/j.cell.2018.03.034 10.1038/nature12040 10.3389/fonc.2021.737127 10.1016/j.cell.2016.12.039 10.1016/j.tcb.2019.05.001 10.1038/s41388-021-02031-w 10.7150/ijbs.67556 10.1016/j.devcel.2015.12.001 10.1038/cddis.2016.189 10.3390/antibiotics12050896 10.1002/btm2.10559 10.18520/cs/v116/i11/1909-1914 10.1038/nature12586 10.3389/fphar.2023.1237456 10.7150/jca.89581 10.1038/nm.4409 10.1093/carcin/bgp220 10.1038/nature25167 10.1002/asi.20317 10.1158/1078-0432.CCR-19-3231 10.1158/0008-5472.CAN-18-3527 10.1126/scitranslmed.aaz6314 10.1038/s42003-022-03135-z |
| ContentType | Journal Article |
| Copyright | 2024 2024 Published by Elsevier Ltd. 2024 Published by Elsevier Ltd. 2024 |
| Copyright_xml | – notice: 2024 – notice: 2024 Published by Elsevier Ltd. – notice: 2024 Published by Elsevier Ltd. 2024 |
| DBID | 6I. AAFTH AAYXX CITATION NPM 7X8 7S9 L.6 5PM DOA |
| DOI | 10.1016/j.heliyon.2024.e31400 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitleList | AGRICOLA MEDLINE - Academic PubMed |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2405-8440 |
| ExternalDocumentID | oai_doaj_org_article_843dd835ad664a96a7d361f8daa4d1c2 PMC11145233 38832277 10_1016_j_heliyon_2024_e31400 S2405844024074310 |
| Genre | Journal Article |
| GeographicLocations | China Texas |
| GeographicLocations_xml | – name: Texas – name: China |
| GroupedDBID | 0R~ 457 53G 5VS 6I. AAEDW AAFTH AAFWJ AALRI AAYWO ABMAC ACGFS ACLIJ ACVFH ADBBV ADCNI ADEZE ADVLN AEUPX AEXQZ AFJKZ AFPKN AFPUW AFTJW AGHFR AIGII AITUG AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ AOIJS APXCP BAWUL BCNDV DIK EBS FDB GROUPED_DOAJ HYE KQ8 M~E O9- OK1 ROL RPM SSZ AAYXX CITATION EJD IPNFZ RIG NPM 7X8 7S9 L.6 5PM |
| ID | FETCH-LOGICAL-c567t-c32bf15992bc8a7adf11f902351eaeaf322e9d1c43d3243fc7c7ab5b86cdec8e3 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 2 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001244584300001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2405-8440 |
| IngestDate | Fri Oct 03 12:50:31 EDT 2025 Thu Aug 21 18:33:31 EDT 2025 Fri Nov 14 18:47:16 EST 2025 Thu Oct 02 12:01:35 EDT 2025 Mon Jul 21 06:00:18 EDT 2025 Thu Nov 27 01:05:19 EST 2025 Tue Nov 18 22:51:06 EST 2025 Wed Dec 10 14:22:56 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 11 |
| Keywords | Cellular reprogramming Bibliometric Metabolism Immunotherapy Cancer |
| Language | English |
| License | This is an open access article under the CC BY-NC-ND license. 2024 Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c567t-c32bf15992bc8a7adf11f902351eaeaf322e9d1c43d3243fc7c7ab5b86cdec8e3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0003-1928-0922 |
| OpenAccessLink | https://doaj.org/article/843dd835ad664a96a7d361f8daa4d1c2 |
| PMID | 38832277 |
| PQID | 3064582946 |
| PQPubID | 23479 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_843dd835ad664a96a7d361f8daa4d1c2 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11145233 proquest_miscellaneous_3153854438 proquest_miscellaneous_3064582946 pubmed_primary_38832277 crossref_citationtrail_10_1016_j_heliyon_2024_e31400 crossref_primary_10_1016_j_heliyon_2024_e31400 elsevier_sciencedirect_doi_10_1016_j_heliyon_2024_e31400 |
| PublicationCentury | 2000 |
| PublicationDate | 2024-06-15 |
| PublicationDateYYYYMMDD | 2024-06-15 |
| PublicationDate_xml | – month: 06 year: 2024 text: 2024-06-15 day: 15 |
| PublicationDecade | 2020 |
| PublicationPlace | England |
| PublicationPlace_xml | – name: England |
| PublicationTitle | Heliyon |
| PublicationTitleAlternate | Heliyon |
| PublicationYear | 2024 |
| Publisher | Elsevier Ltd Elsevier |
| Publisher_xml | – name: Elsevier Ltd – name: Elsevier |
| References | Hu, Locasale, Bielas (bib27) 2013; 31 Li, Zeng, He, Xie (bib13) 2024; 15 Li, Tang, Deng (bib48) 2022; 5 Xiong, Feng, Cheng (bib1) 2019; 29 Tu, Kang, Yang (bib42) 2021; 40 Nakano, Kikushige, Miyawaki (bib8) 2019; 38 Dupuy, Tabariès, Andrzejewski (bib37) 2015; 22 Wang, Yang, Xing (bib43) 2023; 13 Tan, Song (bib10) 2023; 14 DeBerardinis, Lum, Hatzivassiliou, Thompson (bib25) 2008; 7 Zhang, Xu, Ye (bib36) 2021; 15 Li, Choi, Kryczek (bib24) 2023; 41 Gaglio, Metallo, Gameiro (bib26) 2011; 7 Aria, Cuccurullo (bib17) 2017; 11 Srivastava, DeWitt (bib21) 2016; 166 Hanahan, Weinberg (bib18) 2011; 144 Ben-Porath, Thomson, Carey (bib9) 2008; 40 Heiden, Cantley, Thompson (bib20) 2009; 324 Milanovic, Fan, Belenki (bib29) 2018; 553 Sharma, Kelly, Jones (bib6) 2010; 31 Chen (bib16) 2006; 57 Van Eck, Waltman (bib15) 2010; 84 Xiao (bib11) 2023; 27 Abad, Mosteiro, Pantoja (bib3) 2013; 502 Pouliou, Koutsi, Champezou (bib40) 2023; 15 Roy, Hebrok (bib38) 2015; 35 Son, Lyssiotis, Ying (bib39) 2013; 496 Yeung (bib14) 2019; 116 Yao (bib5) 2016; 7 Yang (bib12) 2023; 8 Ohnishi, Semi, Yamamoto (bib2) 2014; 156 Lu, Zhang, Sun (bib44) 2021; 11 Liberti, Locasale (bib53) 2016; 41 Son, Lyssiotis, Ying (bib28) 2013; 496 Gomes, Ramos, Soares, Saraiva (bib35) 2018; 131 Batlle, Clevers (bib23) 2017; 23 Alonso-Vásquez, Fondi, Perrin (bib22) 2023; 12 Liu, Hartman, Li (bib31) 2021; 13 Wang, Wang, Cai (bib30) 2022; 12 Zimmermannova, Caiado, Ferreira, Pereira (bib34) 2021; 12 Zeineldin, Federico, Chen (bib41) 2020; 11 Hou, Shi, Zhang (bib45) 2021; 12 Pavlova, Thompson (bib51) 2016; 23 Galan-Cobo, Sitthideatphaiboon, Qu (bib47) 2019; 79 Malta, Sokolov, Gentles (bib4) 2018; 173 Sathe, Grimes, Lau (bib33) 2020; 26 Chen, Hu, Sui (bib49) 2022; 18 Pavlova, Thompson (bib19) 2016; 23 Zhou, Guo, Ran (bib46) 2023; 577 Vander Heiden, DeBerardinis (bib52) 2017; 168 Xu, Gao, Luo (bib7) 2014; 9 Martinez-Reyes, Chandel (bib50) 2021; 21 Linde, Fan, Koehnke (bib32) 2023; 13 Yeung (10.1016/j.heliyon.2024.e31400_bib14) 2019; 116 Aria (10.1016/j.heliyon.2024.e31400_bib17) 2017; 11 Son (10.1016/j.heliyon.2024.e31400_bib28) 2013; 496 Heiden (10.1016/j.heliyon.2024.e31400_bib20) 2009; 324 Hou (10.1016/j.heliyon.2024.e31400_bib45) 2021; 12 Martinez-Reyes (10.1016/j.heliyon.2024.e31400_bib50) 2021; 21 Gomes (10.1016/j.heliyon.2024.e31400_bib35) 2018; 131 Van Eck (10.1016/j.heliyon.2024.e31400_bib15) 2010; 84 Batlle (10.1016/j.heliyon.2024.e31400_bib23) 2017; 23 Xu (10.1016/j.heliyon.2024.e31400_bib7) 2014; 9 Zhou (10.1016/j.heliyon.2024.e31400_bib46) 2023; 577 Pouliou (10.1016/j.heliyon.2024.e31400_bib40) 2023; 15 Abad (10.1016/j.heliyon.2024.e31400_bib3) 2013; 502 Sathe (10.1016/j.heliyon.2024.e31400_bib33) 2020; 26 Zeineldin (10.1016/j.heliyon.2024.e31400_bib41) 2020; 11 Linde (10.1016/j.heliyon.2024.e31400_bib32) 2023; 13 Li (10.1016/j.heliyon.2024.e31400_bib48) 2022; 5 Roy (10.1016/j.heliyon.2024.e31400_bib38) 2015; 35 Gaglio (10.1016/j.heliyon.2024.e31400_bib26) 2011; 7 Hanahan (10.1016/j.heliyon.2024.e31400_bib18) 2011; 144 Hu (10.1016/j.heliyon.2024.e31400_bib27) 2013; 31 Chen (10.1016/j.heliyon.2024.e31400_bib49) 2022; 18 Son (10.1016/j.heliyon.2024.e31400_bib39) 2013; 496 Dupuy (10.1016/j.heliyon.2024.e31400_bib37) 2015; 22 Srivastava (10.1016/j.heliyon.2024.e31400_bib21) 2016; 166 Zimmermannova (10.1016/j.heliyon.2024.e31400_bib34) 2021; 12 Alonso-Vásquez (10.1016/j.heliyon.2024.e31400_bib22) 2023; 12 Ben-Porath (10.1016/j.heliyon.2024.e31400_bib9) 2008; 40 Chen (10.1016/j.heliyon.2024.e31400_bib16) 2006; 57 Li (10.1016/j.heliyon.2024.e31400_bib13) 2024; 15 Li (10.1016/j.heliyon.2024.e31400_bib24) 2023; 41 Galan-Cobo (10.1016/j.heliyon.2024.e31400_bib47) 2019; 79 DeBerardinis (10.1016/j.heliyon.2024.e31400_bib25) 2008; 7 Liberti (10.1016/j.heliyon.2024.e31400_bib53) 2016; 41 Vander Heiden (10.1016/j.heliyon.2024.e31400_bib52) 2017; 168 Pavlova (10.1016/j.heliyon.2024.e31400_bib19) 2016; 23 Wang (10.1016/j.heliyon.2024.e31400_bib43) 2023; 13 Nakano (10.1016/j.heliyon.2024.e31400_bib8) 2019; 38 Lu (10.1016/j.heliyon.2024.e31400_bib44) 2021; 11 Xiao (10.1016/j.heliyon.2024.e31400_bib11) 2023; 27 Sharma (10.1016/j.heliyon.2024.e31400_bib6) 2010; 31 Wang (10.1016/j.heliyon.2024.e31400_bib30) 2022; 12 Pavlova (10.1016/j.heliyon.2024.e31400_bib51) 2016; 23 Malta (10.1016/j.heliyon.2024.e31400_bib4) 2018; 173 Yang (10.1016/j.heliyon.2024.e31400_bib12) 2023; 8 Milanovic (10.1016/j.heliyon.2024.e31400_bib29) 2018; 553 Tu (10.1016/j.heliyon.2024.e31400_bib42) 2021; 40 Liu (10.1016/j.heliyon.2024.e31400_bib31) 2021; 13 Yao (10.1016/j.heliyon.2024.e31400_bib5) 2016; 7 Tan (10.1016/j.heliyon.2024.e31400_bib10) 2023; 14 Xiong (10.1016/j.heliyon.2024.e31400_bib1) 2019; 29 Ohnishi (10.1016/j.heliyon.2024.e31400_bib2) 2014; 156 Zhang (10.1016/j.heliyon.2024.e31400_bib36) 2021; 15 |
| References_xml | – volume: 7 start-page: 11 year: 2008 end-page: 20 ident: bib25 article-title: The biology of cancer: metabolic reprogramming fuels cell growth and proliferation publication-title: Cell Metabol. – volume: 9 year: 2014 ident: bib7 article-title: EMT and acquisition of stem cell-like properties are involved in spontaneous formation of tumorigenic hybrids between lung cancer and bone marrow-derived mesenchymal stem cells publication-title: PLoS One – volume: 168 year: 2017 ident: bib52 article-title: Understanding the intersections between metabolism and cancer biology publication-title: Cell – volume: 35 start-page: 674 year: 2015 end-page: 684 ident: bib38 article-title: Regulation of cellular identity in cancer publication-title: Dev. Cell – volume: 38 start-page: 780 year: 2019 end-page: 793 ident: bib8 article-title: Dedifferentiation process driven by TGF-beta signaling enhances stem cell properties in human colorectal cancer publication-title: Oncogene – volume: 23 start-page: 27 year: 2016 end-page: 47 ident: bib19 article-title: The emerging hallmarks of cancer metabolism publication-title: Cell Metabol. – volume: 144 start-page: 646 year: 2011 end-page: 674 ident: bib18 article-title: Hallmarks of cancer: the Next generation publication-title: Cell – volume: 40 start-page: 499 year: 2008 end-page: 507 ident: bib9 article-title: An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors publication-title: Nat. Genet. – volume: 324 start-page: 1029 year: 2009 end-page: 1033 ident: bib20 article-title: Understanding the warburg effect: the metabolic Requirements of cell proliferation publication-title: Science – volume: 57 start-page: 359 year: 2006 end-page: 377 ident: bib16 article-title: CiteSpace II: detecting and visualizing emerging trends and transient patterns in scientific literature publication-title: J. Am. Soc. Inf. Sci. – volume: 21 start-page: 669 year: 2021 end-page: 680 ident: bib50 article-title: Cancer metabolism: looking forward publication-title: Nat. Rev. Cancer – volume: 15 start-page: 632 year: 2024 end-page: 644 ident: bib13 article-title: Exploring prognostic immune microenvironment-related genes in head and neck squamous cell carcinoma from the TCGA database publication-title: J. Cancer – volume: 116 year: 2019 ident: bib14 article-title: Comparison between scopus, Web of science, PubMed and publishers for mislabelled review papers publication-title: Curr. Sci. – volume: 31 start-page: 27 year: 2010 end-page: 36 ident: bib6 article-title: Epigenetics in cancer publication-title: Carcinogenesis – volume: 14 year: 2023 ident: bib10 article-title: Research trends and hotspots on the links between caveolin and cancer: bibliometric and visual analysis from 2003 to 2022 publication-title: Front. Pharmacol. – volume: 13 year: 2021 ident: bib31 article-title: Reprogramming lipid metabolism prevents effector T cell senescence and enhances tumor immunotherapy publication-title: Sci. Transl. Med. – volume: 156 start-page: 663 year: 2014 end-page: 677 ident: bib2 article-title: Premature termination of reprogramming in vivo leads to cancer development through altered epigenetic regulation publication-title: Cell – volume: 23 start-page: 1124 year: 2017 end-page: 1134 ident: bib23 article-title: Cancer stem cells revisited publication-title: Nat. Med. – volume: 8 year: 2023 ident: bib12 article-title: Flourishing tumor organoids: history, emerging technology, and application publication-title: Bioengineering & Transla Med – volume: 12 year: 2021 ident: bib34 article-title: Cell fate reprogramming in the era of cancer immunotherapy publication-title: Front. Immunol. – volume: 79 start-page: 3251 year: 2019 end-page: 3267 ident: bib47 article-title: LKB1 and KEAP1/NRF2 pathways cooperatively promote metabolic reprogramming with enhanced glutamine dependence in KRAS-mutant lung adenocarcinoma publication-title: Cancer Res. – volume: 131 start-page: 75 year: 2018 end-page: 86 ident: bib35 article-title: p53 and glucose metabolism: an orchestra to be directed in cancer therapy publication-title: Pharmacol. Res. – volume: 577 year: 2023 ident: bib46 article-title: Combined inhibition of pyruvate dehydrogenase kinase 1 and lactate dehydrogenase a induces metabolic and signaling reprogramming and enhances lung adenocarcinoma cell killing publication-title: Cancer Lett. – volume: 15 start-page: 178 year: 2021 end-page: 207 ident: bib36 article-title: Metabolism and immunity in breast cancer publication-title: Front Med-Prc – volume: 11 year: 2021 ident: bib44 article-title: Multi-omics analysis of fatty acid metabolism in thyroid carcinoma publication-title: Front. Oncol. – volume: 84 start-page: 523 year: 2010 end-page: 538 ident: bib15 article-title: Software survey: VOSviewer, a computer program for bibliometric mapping publication-title: Scientometrics – volume: 5 start-page: 198 year: 2022 ident: bib48 article-title: Identifying metabolic reprogramming phenotypes with glycolysis-lipid metabolism discoordination and intercellular communication for lung adenocarcinoma metastasis publication-title: Commun. Biol. – volume: 18 start-page: 522 year: 2022 end-page: 535 ident: bib49 article-title: LncRNA FAM83A-AS1 facilitates tumor proliferation and the migration via the HIF-1alpha/glycolysis axis in lung adenocarcinoma publication-title: Int. J. Biol. Sci. – volume: 11 year: 2020 ident: bib41 article-title: Amplification and mutations are incompatible in neuroblastoma publication-title: Nat. Commun. – volume: 29 start-page: 623 year: 2019 end-page: 634 ident: bib1 article-title: Cellular reprogramming as a therapeutic target in cancer publication-title: Trends Cell Biol. – volume: 26 start-page: 2640 year: 2020 end-page: 2653 ident: bib33 article-title: Single-cell genomic characterization reveals the cellular reprogramming of the gastric tumor microenvironment publication-title: Clin. Cancer Res. – volume: 27 start-page: 47 year: 2023 ident: bib11 article-title: Emerging biomaterials for tumor immunotherapy publication-title: Biomater. Res. – volume: 12 start-page: 1871 year: 2022 end-page: 1884 ident: bib30 article-title: Nuclear TIGAR mediates an epigenetic and metabolic autoregulatory loop NRF2 in cancer therapeutic resistance publication-title: Acta Pharm. Sin. B – volume: 496 start-page: 101 year: 2013 ident: bib28 article-title: Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway publication-title: Nature – volume: 553 start-page: 96 year: 2018 ident: bib29 article-title: Senescence-associated reprogramming promotes cancer stemness publication-title: Nature – volume: 41 start-page: 304 year: 2023 ident: bib24 article-title: Intersection of immune and oncometabolic pathways drives cancer hyperprogression during immunotherapy publication-title: Cancer Cell – volume: 13 start-page: 1164 year: 2023 end-page: 1185 ident: bib32 article-title: Reprogramming cancer into antigen- presenting cells as a novel immunotherapy publication-title: Cancer Discov. – volume: 40 start-page: 6417 year: 2021 end-page: 6429 ident: bib42 article-title: USP29 coordinates MYC and HIF1α stabilization to promote tumor metabolism and progression publication-title: Oncogene – volume: 11 start-page: 959 year: 2017 end-page: 975 ident: bib17 article-title: bibliometrix: an R-tool for comprehensive science mapping analysis publication-title: Journal of Informetrics – volume: 15 year: 2023 ident: bib40 article-title: Amplifications and metabolic rewiring in neuroblastoma publication-title: Cancers – volume: 22 start-page: 577 year: 2015 end-page: 589 ident: bib37 article-title: PDK1-Dependent metabolic reprogramming dictates metastatic potential in breast cancer publication-title: Cell Metabol. – volume: 496 start-page: 101 year: 2013 ident: bib39 article-title: Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway publication-title: Nature – volume: 31 year: 2013 ident: bib27 article-title: Heterogeneity of tumor-induced gene expression changes in the human metabolic network publication-title: Nat. Biotechnol. – volume: 12 start-page: 896 year: 2023 ident: bib22 article-title: Understanding antimicrobial resistance using genome-scale metabolic modeling publication-title: Antibiotics – volume: 13 year: 2023 ident: bib43 article-title: Combined metabolomic and lipidomic analysis uncovers metabolic profile and biomarkers for papillary thyroid carcinoma publication-title: Sci. Rep. – volume: 7 year: 2016 ident: bib5 article-title: Tumorigenic potential is restored during differentiation in fusion-reprogrammed cancer cells publication-title: Cell Death Dis. – volume: 7 year: 2011 ident: bib26 article-title: Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth publication-title: Mol. Syst. Biol. – volume: 12 start-page: 347 year: 2021 ident: bib45 article-title: LDHA induces EMT gene transcription and regulates autophagy to promote the metastasis and tumorigenesis of papillary thyroid carcinoma publication-title: Cell Death Dis. – volume: 173 start-page: 338 year: 2018 ident: bib4 article-title: Machine learning identifies stemness features associated with oncogenic dedifferentiation publication-title: Cell – volume: 166 start-page: 1386 year: 2016 end-page: 1396 ident: bib21 article-title: In vivo cellular reprogramming: the Next generation publication-title: Cell – volume: 502 start-page: 340 year: 2013 ident: bib3 article-title: Reprogramming produces teratomas and iPS cells with totipotency features publication-title: Nature – volume: 23 start-page: 27 year: 2016 end-page: 47 ident: bib51 article-title: The emerging hallmarks of cancer metabolism publication-title: Cell Metabol. – volume: 41 year: 2016 ident: bib53 article-title: The warburg effect: how does it benefit cancer cells? (vol 41, pg 211, 2016) publication-title: Trends Biochem. Sci. – volume: 12 start-page: 1871 issue: 4 year: 2022 ident: 10.1016/j.heliyon.2024.e31400_bib30 article-title: Nuclear TIGAR mediates an epigenetic and metabolic autoregulatory loop NRF2 in cancer therapeutic resistance publication-title: Acta Pharm. Sin. B doi: 10.1016/j.apsb.2021.10.015 – volume: 13 issue: 1 year: 2023 ident: 10.1016/j.heliyon.2024.e31400_bib43 article-title: Combined metabolomic and lipidomic analysis uncovers metabolic profile and biomarkers for papillary thyroid carcinoma publication-title: Sci. Rep. – volume: 11 issue: 1 year: 2020 ident: 10.1016/j.heliyon.2024.e31400_bib41 article-title: Amplification and mutations are incompatible in neuroblastoma publication-title: Nat. Commun. doi: 10.1038/s41467-020-14682-6 – volume: 15 start-page: 178 issue: 2 year: 2021 ident: 10.1016/j.heliyon.2024.e31400_bib36 article-title: Metabolism and immunity in breast cancer publication-title: Front Med-Prc doi: 10.1007/s11684-020-0793-6 – volume: 38 start-page: 780 issue: 6 year: 2019 ident: 10.1016/j.heliyon.2024.e31400_bib8 article-title: Dedifferentiation process driven by TGF-beta signaling enhances stem cell properties in human colorectal cancer publication-title: Oncogene doi: 10.1038/s41388-018-0480-0 – volume: 84 start-page: 523 year: 2010 ident: 10.1016/j.heliyon.2024.e31400_bib15 article-title: Software survey: VOSviewer, a computer program for bibliometric mapping publication-title: Scientometrics doi: 10.1007/s11192-009-0146-3 – volume: 577 year: 2023 ident: 10.1016/j.heliyon.2024.e31400_bib46 article-title: Combined inhibition of pyruvate dehydrogenase kinase 1 and lactate dehydrogenase a induces metabolic and signaling reprogramming and enhances lung adenocarcinoma cell killing publication-title: Cancer Lett. doi: 10.1016/j.canlet.2023.216425 – volume: 23 start-page: 27 issue: 1 year: 2016 ident: 10.1016/j.heliyon.2024.e31400_bib19 article-title: The emerging hallmarks of cancer metabolism publication-title: Cell Metabol. doi: 10.1016/j.cmet.2015.12.006 – volume: 27 start-page: 47 year: 2023 ident: 10.1016/j.heliyon.2024.e31400_bib11 article-title: Emerging biomaterials for tumor immunotherapy publication-title: Biomater. Res. doi: 10.1186/s40824-023-00369-8 – volume: 156 start-page: 663 issue: 4 year: 2014 ident: 10.1016/j.heliyon.2024.e31400_bib2 article-title: Premature termination of reprogramming in vivo leads to cancer development through altered epigenetic regulation publication-title: Cell doi: 10.1016/j.cell.2014.01.005 – volume: 7 start-page: 11 issue: 1 year: 2008 ident: 10.1016/j.heliyon.2024.e31400_bib25 article-title: The biology of cancer: metabolic reprogramming fuels cell growth and proliferation publication-title: Cell Metabol. doi: 10.1016/j.cmet.2007.10.002 – volume: 13 start-page: 1164 issue: 5 year: 2023 ident: 10.1016/j.heliyon.2024.e31400_bib32 article-title: Reprogramming cancer into antigen- presenting cells as a novel immunotherapy publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-21-0502 – volume: 9 issue: 2 year: 2014 ident: 10.1016/j.heliyon.2024.e31400_bib7 article-title: EMT and acquisition of stem cell-like properties are involved in spontaneous formation of tumorigenic hybrids between lung cancer and bone marrow-derived mesenchymal stem cells publication-title: PLoS One doi: 10.1371/journal.pone.0087893 – volume: 324 start-page: 1029 issue: 5930 year: 2009 ident: 10.1016/j.heliyon.2024.e31400_bib20 article-title: Understanding the warburg effect: the metabolic Requirements of cell proliferation publication-title: Science doi: 10.1126/science.1160809 – volume: 23 start-page: 27 issue: 1 year: 2016 ident: 10.1016/j.heliyon.2024.e31400_bib51 article-title: The emerging hallmarks of cancer metabolism publication-title: Cell Metabol. doi: 10.1016/j.cmet.2015.12.006 – volume: 7 year: 2011 ident: 10.1016/j.heliyon.2024.e31400_bib26 article-title: Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth publication-title: Mol. Syst. Biol. doi: 10.1038/msb.2011.56 – volume: 144 start-page: 646 issue: 5 year: 2011 ident: 10.1016/j.heliyon.2024.e31400_bib18 article-title: Hallmarks of cancer: the Next generation publication-title: Cell doi: 10.1016/j.cell.2011.02.013 – volume: 12 year: 2021 ident: 10.1016/j.heliyon.2024.e31400_bib34 article-title: Cell fate reprogramming in the era of cancer immunotherapy publication-title: Front. Immunol. doi: 10.3389/fimmu.2021.714822 – volume: 166 start-page: 1386 issue: 6 year: 2016 ident: 10.1016/j.heliyon.2024.e31400_bib21 article-title: In vivo cellular reprogramming: the Next generation publication-title: Cell doi: 10.1016/j.cell.2016.08.055 – volume: 12 start-page: 347 issue: 4 year: 2021 ident: 10.1016/j.heliyon.2024.e31400_bib45 article-title: LDHA induces EMT gene transcription and regulates autophagy to promote the metastasis and tumorigenesis of papillary thyroid carcinoma publication-title: Cell Death Dis. doi: 10.1038/s41419-021-03641-8 – volume: 21 start-page: 669 issue: 10 year: 2021 ident: 10.1016/j.heliyon.2024.e31400_bib50 article-title: Cancer metabolism: looking forward publication-title: Nat. Rev. Cancer doi: 10.1038/s41568-021-00378-6 – volume: 40 start-page: 499 issue: 5 year: 2008 ident: 10.1016/j.heliyon.2024.e31400_bib9 article-title: An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors publication-title: Nat. Genet. doi: 10.1038/ng.127 – volume: 131 start-page: 75 year: 2018 ident: 10.1016/j.heliyon.2024.e31400_bib35 article-title: p53 and glucose metabolism: an orchestra to be directed in cancer therapy publication-title: Pharmacol. Res. doi: 10.1016/j.phrs.2018.03.015 – volume: 22 start-page: 577 issue: 4 year: 2015 ident: 10.1016/j.heliyon.2024.e31400_bib37 article-title: PDK1-Dependent metabolic reprogramming dictates metastatic potential in breast cancer publication-title: Cell Metabol. doi: 10.1016/j.cmet.2015.08.007 – volume: 11 start-page: 959 year: 2017 ident: 10.1016/j.heliyon.2024.e31400_bib17 article-title: bibliometrix: an R-tool for comprehensive science mapping analysis publication-title: Journal of Informetrics doi: 10.1016/j.joi.2017.08.007 – volume: 31 issue: 6 year: 2013 ident: 10.1016/j.heliyon.2024.e31400_bib27 article-title: Heterogeneity of tumor-induced gene expression changes in the human metabolic network publication-title: Nat. Biotechnol. doi: 10.1038/nbt.2530 – volume: 41 issue: 3 year: 2016 ident: 10.1016/j.heliyon.2024.e31400_bib53 article-title: The warburg effect: how does it benefit cancer cells? (vol 41, pg 211, 2016) publication-title: Trends Biochem. Sci. – volume: 41 start-page: 304 issue: 2 year: 2023 ident: 10.1016/j.heliyon.2024.e31400_bib24 article-title: Intersection of immune and oncometabolic pathways drives cancer hyperprogression during immunotherapy publication-title: Cancer Cell doi: 10.1016/j.ccell.2022.12.008 – volume: 15 issue: 19 year: 2023 ident: 10.1016/j.heliyon.2024.e31400_bib40 article-title: Amplifications and metabolic rewiring in neuroblastoma publication-title: Cancers doi: 10.3390/cancers15194803 – volume: 173 start-page: 338 issue: 2 year: 2018 ident: 10.1016/j.heliyon.2024.e31400_bib4 article-title: Machine learning identifies stemness features associated with oncogenic dedifferentiation publication-title: Cell doi: 10.1016/j.cell.2018.03.034 – volume: 496 start-page: 101 issue: 7443 year: 2013 ident: 10.1016/j.heliyon.2024.e31400_bib28 article-title: Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway publication-title: Nature doi: 10.1038/nature12040 – volume: 496 start-page: 101 issue: 7443 year: 2013 ident: 10.1016/j.heliyon.2024.e31400_bib39 article-title: Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway publication-title: Nature doi: 10.1038/nature12040 – volume: 11 year: 2021 ident: 10.1016/j.heliyon.2024.e31400_bib44 article-title: Multi-omics analysis of fatty acid metabolism in thyroid carcinoma publication-title: Front. Oncol. doi: 10.3389/fonc.2021.737127 – volume: 168 issue: 4 year: 2017 ident: 10.1016/j.heliyon.2024.e31400_bib52 article-title: Understanding the intersections between metabolism and cancer biology publication-title: Cell doi: 10.1016/j.cell.2016.12.039 – volume: 29 start-page: 623 issue: 8 year: 2019 ident: 10.1016/j.heliyon.2024.e31400_bib1 article-title: Cellular reprogramming as a therapeutic target in cancer publication-title: Trends Cell Biol. doi: 10.1016/j.tcb.2019.05.001 – volume: 40 start-page: 6417 issue: 46 year: 2021 ident: 10.1016/j.heliyon.2024.e31400_bib42 article-title: USP29 coordinates MYC and HIF1α stabilization to promote tumor metabolism and progression publication-title: Oncogene doi: 10.1038/s41388-021-02031-w – volume: 18 start-page: 522 issue: 2 year: 2022 ident: 10.1016/j.heliyon.2024.e31400_bib49 article-title: LncRNA FAM83A-AS1 facilitates tumor proliferation and the migration via the HIF-1alpha/glycolysis axis in lung adenocarcinoma publication-title: Int. J. Biol. Sci. doi: 10.7150/ijbs.67556 – volume: 35 start-page: 674 issue: 6 year: 2015 ident: 10.1016/j.heliyon.2024.e31400_bib38 article-title: Regulation of cellular identity in cancer publication-title: Dev. Cell doi: 10.1016/j.devcel.2015.12.001 – volume: 7 year: 2016 ident: 10.1016/j.heliyon.2024.e31400_bib5 article-title: Tumorigenic potential is restored during differentiation in fusion-reprogrammed cancer cells publication-title: Cell Death Dis. doi: 10.1038/cddis.2016.189 – volume: 12 start-page: 896 year: 2023 ident: 10.1016/j.heliyon.2024.e31400_bib22 article-title: Understanding antimicrobial resistance using genome-scale metabolic modeling publication-title: Antibiotics doi: 10.3390/antibiotics12050896 – volume: 8 year: 2023 ident: 10.1016/j.heliyon.2024.e31400_bib12 article-title: Flourishing tumor organoids: history, emerging technology, and application publication-title: Bioengineering & Transla Med doi: 10.1002/btm2.10559 – volume: 116 year: 2019 ident: 10.1016/j.heliyon.2024.e31400_bib14 article-title: Comparison between scopus, Web of science, PubMed and publishers for mislabelled review papers publication-title: Curr. Sci. doi: 10.18520/cs/v116/i11/1909-1914 – volume: 502 start-page: 340 issue: 7471 year: 2013 ident: 10.1016/j.heliyon.2024.e31400_bib3 article-title: Reprogramming produces teratomas and iPS cells with totipotency features publication-title: Nature doi: 10.1038/nature12586 – volume: 14 year: 2023 ident: 10.1016/j.heliyon.2024.e31400_bib10 article-title: Research trends and hotspots on the links between caveolin and cancer: bibliometric and visual analysis from 2003 to 2022 publication-title: Front. Pharmacol. doi: 10.3389/fphar.2023.1237456 – volume: 15 start-page: 632 year: 2024 ident: 10.1016/j.heliyon.2024.e31400_bib13 article-title: Exploring prognostic immune microenvironment-related genes in head and neck squamous cell carcinoma from the TCGA database publication-title: J. Cancer doi: 10.7150/jca.89581 – volume: 23 start-page: 1124 issue: 10 year: 2017 ident: 10.1016/j.heliyon.2024.e31400_bib23 article-title: Cancer stem cells revisited publication-title: Nat. Med. doi: 10.1038/nm.4409 – volume: 31 start-page: 27 issue: 1 year: 2010 ident: 10.1016/j.heliyon.2024.e31400_bib6 article-title: Epigenetics in cancer publication-title: Carcinogenesis doi: 10.1093/carcin/bgp220 – volume: 553 start-page: 96 issue: 7686 year: 2018 ident: 10.1016/j.heliyon.2024.e31400_bib29 article-title: Senescence-associated reprogramming promotes cancer stemness publication-title: Nature doi: 10.1038/nature25167 – volume: 57 start-page: 359 year: 2006 ident: 10.1016/j.heliyon.2024.e31400_bib16 article-title: CiteSpace II: detecting and visualizing emerging trends and transient patterns in scientific literature publication-title: J. Am. Soc. Inf. Sci. doi: 10.1002/asi.20317 – volume: 26 start-page: 2640 issue: 11 year: 2020 ident: 10.1016/j.heliyon.2024.e31400_bib33 article-title: Single-cell genomic characterization reveals the cellular reprogramming of the gastric tumor microenvironment publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-19-3231 – volume: 79 start-page: 3251 issue: 13 year: 2019 ident: 10.1016/j.heliyon.2024.e31400_bib47 article-title: LKB1 and KEAP1/NRF2 pathways cooperatively promote metabolic reprogramming with enhanced glutamine dependence in KRAS-mutant lung adenocarcinoma publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-18-3527 – volume: 13 issue: 587 year: 2021 ident: 10.1016/j.heliyon.2024.e31400_bib31 article-title: Reprogramming lipid metabolism prevents effector T cell senescence and enhances tumor immunotherapy publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.aaz6314 – volume: 5 start-page: 198 issue: 1 year: 2022 ident: 10.1016/j.heliyon.2024.e31400_bib48 article-title: Identifying metabolic reprogramming phenotypes with glycolysis-lipid metabolism discoordination and intercellular communication for lung adenocarcinoma metastasis publication-title: Commun. Biol. doi: 10.1038/s42003-022-03135-z |
| SSID | ssj0001586973 |
| Score | 2.2797756 |
| Snippet | Recent research has reevaluated the traditional view of cancer's linear progression and recurrence by introducing cellular reprogramming a process in which... |
| SourceID | doaj pubmedcentral proquest pubmed crossref elsevier |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | e31400 |
| SubjectTerms | Bibliometric bibliometric analysis Cancer cancer recurrence cancer therapy Cellular reprogramming China data collection domain epigenetics Immunotherapy Metabolism Texas |
| Title | Deciphering two decades of cellular reprogramming in cancer: A bibliometric analysis of evolving trends and research frontiers |
| URI | https://dx.doi.org/10.1016/j.heliyon.2024.e31400 https://www.ncbi.nlm.nih.gov/pubmed/38832277 https://www.proquest.com/docview/3064582946 https://www.proquest.com/docview/3153854438 https://pubmed.ncbi.nlm.nih.gov/PMC11145233 https://doaj.org/article/843dd835ad664a96a7d361f8daa4d1c2 |
| Volume | 10 |
| WOSCitedRecordID | wos001244584300001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2405-8440 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001586973 issn: 2405-8440 databaseCode: DOA dateStart: 20150101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2405-8440 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001586973 issn: 2405-8440 databaseCode: M~E dateStart: 20150101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELZghRAXxJvyWBmJa7pN7fjBbYFdcdkVB5B6s_ykWZVk1XYXcdnfzoyTlgYkeuESRfEj9jw842T8DSFvJbPSC1YWlS19wZPThdPaguJxGz3nPKZJTjYhz8_VbKY_76T6wpiwDh64I9yR4iwEcBNsEIJbLawMTJRJBWt5KH1efSdS72ymuvPBSmjJfh_ZOboYz-Oi_tki5umUjyODncVkYIwyZv_AJv3tc_4ZOrlji04fkPu9E0mPu8E_JLdi84jcPet_kz8mNx-jry_zyb5vdP2jpSFiGPyKtonil3oMPaUIZ5ljs75jrbqhHgVg-Y4eU1e7BR7LR_R-anvYEmwcYTG7zp3mUFooC7SHC5rThFgImFn7Cfl6evLlw6eiT7RQ-ErIdeHZ1CXwa_TUeWWlDaksk0YknDLaaBMofdRAbGAF-F8seemldZVTwsP4VWRPyUHTNvE5oUl6WCUQ1SjCRrMUtrI6Wa0c3HMXyhHhG4ob36OQYzKMhdmEm12YnlEGGWU6Ro3IeNvssoPh2NfgPbJzWxlRtPMDkC3Ty5bZJ1sjojbCYHqHpHM0oKt63_vfbITHgMIib20T26uVwS1fpaaai3_UQTuEyIRqRJ51AredCVO4CEsJgxuI4mCqw5KmnmfgcLBrvJoy9uJ_EOcluYfzxbC5snpFDtbLq_ia3PHX63q1PCS35UwdZqWE69nNyS-RhkJB |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Deciphering+two+decades+of+cellular+reprogramming+in+cancer%3A+A+bibliometric+analysis+of+evolving+trends+and+research+frontiers&rft.jtitle=Heliyon&rft.au=Liang%2C+Jinghao&rft.au=Lin%2C+Yijian&rft.au=Liu%2C+Yuanqing&rft.au=Lin%2C+Hongmiao&rft.date=2024-06-15&rft.issn=2405-8440&rft.eissn=2405-8440&rft.volume=10&rft.issue=11&rft.spage=e31400&rft_id=info:doi/10.1016%2Fj.heliyon.2024.e31400&rft_id=info%3Apmid%2F38832277&rft.externalDocID=38832277 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2405-8440&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2405-8440&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2405-8440&client=summon |